Primary Resistance to RET Inhibition in a RET Fusion-Positive Pancreatic Neuroendocrine Carcinoma.

Saved in:
Bibliographic Details
Title: Primary Resistance to RET Inhibition in a RET Fusion-Positive Pancreatic Neuroendocrine Carcinoma.
Authors: McKinley BJ; Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA., Coston TW; Division of Medical Oncology, Duke, Raleigh, NC, USA., Starr JS; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, USA.
Source: The oncologist [Oncologist] 2025 Jan 17; Vol. 30 (1).
Publication Type: Journal Article; Case Reports
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1549-490X
DOI:10.1093/oncolo/oyae034